UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 583

Sortiert nach

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

British journal of dermatology (1951), 2007-12, Vol.157 (6), p.1275-1277

2007

Volltextzugriff (PDF)

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2014-10, Vol.73 (10), p.1906-1908

2014

Volltextzugriff (PDF)

FRI0298 Treatment Patterns among Adult Systemic Sclerosis Patients in A US Healthcare Claims Population

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.543-543

2016

Volltextzugriff (PDF)

FRI0200 Incident Malignancies Following Initiation of Rituximab for Rheumatoid Arthritis: Analysis from The Sunstone Registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.503-503

2016

Volltextzugriff (PDF)

FRI0268 Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from The Open-Label Period of The Fasscinate Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.531-532

2016

Volltextzugriff (PDF)

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial

British journal of dermatology (1951), 2005-12, Vol.153 (6), p.1192-1199

2005

Volltextzugriff (PDF)

OP0054 Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 48 Data from the Fasscinate Trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.87-88

2015

Volltextzugriff (PDF)

Integrated safety in tocilizumab clinical trials

Arthritis research & therapy, 2011-01, Vol.13 (5), p.R141-R141

2011

Volltextzugriff (PDF)

Urinary Iodine, Perchlorate, and Thiocyanate Concentrations in U.S. Lactating Women

Thyroid (New York, N.Y.), 2017-12, Vol.27 (12), p.1574

2017

Volltextzugriff (PDF)

Environmental perchlorate and thiocyanate exposures and infant serum thyroid function

Thyroid (New York, N.Y.), 2012-09, Vol.22 (9), p.938

2012

Volltextzugriff (PDF)

Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis

British journal of dermatology (1951), 2007-01, Vol.156 (1), p.138-142

2007

Volltextzugriff (PDF)

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

The Lancet (British edition), 2006-01, Vol.367 (9504), p.29-35

2006

Volltextzugriff (PDF)

SARS-CoV-2 Infection During Pregnancy

Deutsches Ärzteblatt international, 2022-09, Vol.119 (35-36), p.588-594

2022

Volltextzugriff (PDF)

Effects of two novel cationic staphylococcal proteins (NP-taseand p70) and enterotoxin B on IgE synthesis and interleukin-4 and interferon-γ production in patients with atopic dermatitis

British journal of dermatology (1951), 2000-04, Vol.142 (4), p.680-687

2000

Volltextzugriff (PDF)

ECM et TEV dans le développement clinique du filgotinib dans la polyarthrite rhumatoïde : analyse intégrée des essais cliniques de phases 2 et 3

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A111-A112

2021

Volltextzugriff (PDF)

Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database

Journal of the American Academy of Dermatology, 2006-03, Vol.54 (3), p.S92-S100

2006

Volltextzugriff (PDF)

Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial

Journal of the American Academy of Dermatology, 2005-11, Vol.53 (5), p.887-889

2005

Volltextzugriff (PDF)

CD40L Blockade Prevents Autoimmune Diabetes by Induction of Bitypic NK/DC Regulatory Cells

Immunity (Cambridge, Mass.), 2002-03, Vol.16 (3), p.403-415

2002

Volltextzugriff (PDF)

Efficacité et tolérance du filgotinib chez les patients atteints de polyarthrite rhumatoïde (PR) présentant une réponse inadéquate au méthotrexate (RI-MTX) : résultats de l’étude FINCH 1 à 52 semaines

Revue du rhumatisme (Ed. française : 1993), 2020-12, Vol.87, p.A18-A19

2020

Volltextzugriff (PDF)

Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy

The Journal of dermatological treatment, 2006, Vol.17 (1), p.9-17

2006

Volltextzugriff (PDF)

Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial

Journal of the American Academy of Dermatology, 2006-03, Vol.54 (3), p.S112-S119

2006

Volltextzugriff (PDF)

A double blind, placebo‐controlled, crossover therapy study with natural human IL‐2 (nhuIL‐2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID)

Clinical and experimental immunology, 1997-11, Vol.110 (2), p.167-173

1997

Volltextzugriff (PDF)

PF348 LONG TERM FOLLOW‐UP OF PNH PATIENTS TREATED WITH THE SMART ANTI‐HC5 ANTIBODY (SKY59/RO7112689) IN THE OPEN LABEL EXTENSION (OLE) OF THE COMPOSER TRIAL

HemaSphere, 2019-06, Vol.3 (S1), p.125-126

2019

Volltextzugriff (PDF)

Possible role of IL‐2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency

Clinical and experimental immunology, 1992-08, Vol.89 (2), p.204-210

1992

Volltextzugriff (PDF)

Hypoxia-inducible Factor Prolyl-4-hydroxylase PHD2 Protein Abundance Depends on Integral Membrane Anchoring of FKBP38

The Journal of biological chemistry, 2009-08, Vol.284 (34), p.23046-23058

2009

Volltextzugriff (PDF)

1 – 25 von 583

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(427)
Mit Volltextzugriff
(440)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(323)
Life Sciences & Biomedicine
(294)
Humans
(184)
Female
(133)
Biological And Medical Sciences
(119)
Animals
(114)
Male
(108)
Nutrition & Dietetics
(86)
Fundamental And Applied Biological Sciences. Psychology
(81)
Adult
(78)
Biochemistry & Molecular Biology
(69)
Medical Sciences
(53)
Middle Aged
(49)
Double-Blind Method
(46)
Diet
(44)
Physical Sciences
(44)
Food Science & Technology
(38)
Chemistry
(36)
Fatty Acids
(36)
Nutrition
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis

FRI0298 Treatment Patterns among Adult Systemic Sclerosis Patients in A US Healthcare Claims Population

FRI0200 Incident Malignancies Following Initiation of Rituximab for Rheumatoid Arthritis: Analysis from The Sunstone Registry

FRI0268 Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from The Open-Label Period of The Fasscinate Trial

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial

OP0054 Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 48 Data from the Fasscinate Trial

Integrated safety in tocilizumab clinical trials

Urinary Iodine, Perchlorate, and Thiocyanate Concentrations in U.S. Lactating Women

Environmental perchlorate and thiocyanate exposures and infant serum thyroid function

Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

SARS-CoV-2 Infection During Pregnancy

Effects of two novel cationic staphylococcal proteins (NP-taseand p70) and enterotoxin B on IgE synthesis and interleukin-4 and interferon-γ production in patients with atopic dermatitis

ECM et TEV dans le développement clinique du filgotinib dans la polyarthrite rhumatoïde : analyse intégrée des essais cliniques de phases 2 et 3

Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database

Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial

CD40L Blockade Prevents Autoimmune Diabetes by Induction of Bitypic NK/DC Regulatory Cells

Efficacité et tolérance du filgotinib chez les patients atteints de polyarthrite rhumatoïde (PR) présentant une réponse inadéquate au méthotrexate (RI-MTX) : résultats de l’étude FINCH 1 à 52 semaines

Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy

Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial

A double blind, placebo‐controlled, crossover therapy study with natural human IL‐2 (nhuIL‐2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID)

PF348 LONG TERM FOLLOW‐UP OF PNH PATIENTS TREATED WITH THE SMART ANTI‐HC5 ANTIBODY (SKY59/RO7112689) IN THE OPEN LABEL EXTENSION (OLE) OF THE COMPOSER TRIAL

Possible role of IL‐2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency

Hypoxia-inducible Factor Prolyl-4-hydroxylase PHD2 Protein Abundance Depends on Integral Membrane Anchoring of FKBP38

Suchergebnisse filtern